Your search returned 5 results.

Results
	1.	Peripheral blood CD34+ cell enumeration as a predictor of apheresis yield: an analysis of more than 1,000 collections. [electronic resource] by Gambell, Peter Herbert, Kirsten Dickinson, Michael Stokes, Kerrie Bressel, Mathias Wall, Dominic Harrison, Simon Prince, H Miles Producer: 20130503 In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation. [electronic resource] by Fleming, Shaun Harrison, Simon J Blombery, Piers Joyce, Trish Stokes, Kerrie Seymour, John F Prince, H Miles Ritchie, David Producer: 20150330 In: Clinical lymphoma, myeloma & leukemia vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A randomized cross-over trial to determine the effect of Cremophor EL on the pharmacodynamics and pharmacokinetics of carboplatin chemotherapy. [electronic resource] by Loi, Sherene Rischin, Danny Michael, Michael Yuen, Kally Stokes, Kerrie H Ellis, Andrew G Millward, Michael J Webster, Lorraine K Producer: 20041202 In: Cancer chemotherapy and pharmacology vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A risk-adapted protocol for delayed administration of filgrastim after high-dose chemotherapy and autologous stem cell transplantation. [electronic resource] by Khot, Amit Dickinson, Michael Stokes, Kerrie Harrison, Simon Burbury, Kate Fleming, Shaun Wall, Dominic Gambell, Peter Prince, H Miles Seymour, John F Ritchie, David Producer: 20131115 In: Clinical lymphoma, myeloma & leukemia vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma. [electronic resource] by Doo, Nicole Wong Thompson, Philip A Prince, H Miles Seymour, John F Ritchie, David Stokes, Kerrie Burbury, Kate Wolf, Max Joyce, Trish Harrison, Simon J Producer: 20140210 In: Leukemia & lymphoma vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)